{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:34:37Z","timestamp":1771536877481,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Pharmaceuticals (DOP), Ministry of chemicals & fertilisers"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.cbi.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T06:14:48Z","timestamp":1439532888000},"page":"146-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Preclinical drug metabolism and pharmacokinetics of salinomycin, a potential candidate for targeting human cancer stem cells"],"prefix":"10.1016","volume":"240","author":[{"given":"Kahkashan","family":"Resham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prinesh N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Thummuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Guntuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanya","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh B.","family":"Bambal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.G.M.","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2015.08.007_bib1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7164\/antibiotics.27.814","article-title":"Salinomycin, a new polyether antibiotic","volume":"27","author":"Miyazaki","year":"1974","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.cbi.2015.08.007_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/mmr_00000296","article-title":"Salinomycin in cancer: a new mission for an old agent","volume":"3","author":"Naujokat","year":"2010","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cbi.2015.08.007_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","article-title":"Salinomycin selectively targets \u2018CD133+\u2019 cell subpopulations and decreases malignant traits in colorectal cancer lines","volume":"18","author":"Dong","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cbi.2015.08.007_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.biopha.2011.06.006","article-title":"Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancer","volume":"65","author":"Zhi","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2015.08.007_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157340611794859307","article-title":"Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells","volume":"7","author":"Wang","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.cbi.2015.08.007_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2011.07.016","article-title":"Salinomycin inhibits osteosarcoma by targeting its tumor stem cells","volume":"311","author":"Tang","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2015.08.007_bib7","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.4161\/cc.10.12.15883","article-title":"Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas","volume":"10","author":"Lee","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2015.08.007_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/bjc.2011.530","article-title":"Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress","volume":"106","author":"Ketola","year":"2012","journal-title":"Br. J. cancer"},{"key":"10.1016\/j.cbi.2015.08.007_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1747-0285.2011.01287.x","article-title":"Salinomycin- a new cancer drug candidate","volume":"79","author":"Huczynski","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2015.08.007_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1476-5381.2010.01089.x","article-title":"Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein","volume":"162","author":"Kim","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2015.08.007_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10637-011-9685-6","article-title":"Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest","volume":"30","author":"Kim","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.cbi.2015.08.007_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01041-07","article-title":"P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin","volume":"52","author":"Lagas","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2015.08.007_bib13","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Lu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cbi.2015.08.007_bib14","article-title":"Salinomycin as a drug for targeting human cancer stem cells","volume":"2012","author":"Naujokat","year":"2012","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cbi.2015.08.007_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2011.12.141","article-title":"Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest","volume":"418","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2015.08.007_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.biomaterials.2011.09.072","article-title":"The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.cbi.2015.08.007_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2011.05.030","article-title":"Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells","volume":"313","author":"Zhang","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2015.08.007_bib18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2015.08.007_bib19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1124\/dmd.112.046136","article-title":"The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5","volume":"40","author":"Morrison","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2015.08.007_bib20","series-title":"Species Differences between Mouse, Rat, Dog, Monkey and Human CYP-mediated Drug Metabolism, Inhibition and Induction","author":"Martignoni","year":"2006"},{"key":"10.1016\/j.cbi.2015.08.007_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.31.7.833","article-title":"Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat","volume":"31","author":"Kobayashi","year":"2003","journal-title":"Drug Metab. Dispos."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715300363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:37:23Z","timestamp":1757857043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279715300363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"alternative-id":["S0009279715300363"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2015.08.007","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical drug metabolism and pharmacokinetics of salinomycin, a potential candidate for targeting human cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}